Effects of moderate hypothermia on norepinephrine release evoked by ouabain, tyramine and cyanide

Journal of Cardiovascular Pharmacology

Volumn 41, Issue SUPPL. 1, 2003, Pages

  Kitagawa, Hirotoshi ^a,c   Yamazaki, Toji ^b   Akiyama, Tsuyoshi ^b   Mori, Hidezo ^b   Sunagawa, Kenji ^b  

^a NAGAHAMA CITY HOSPITAL   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Desipramine; Dialysis technique; Heart; Norepinephrine; Sympathetic nerve

Indexed keywords

CYANIDE; DESIPRAMINE; NORADRENALIN; NORADRENALIN UPTAKE INHIBITOR; OUABAIN; TYRAMINE;

ACTIVE TRANSPORT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CAT; CONFERENCE PAPER; CONTROLLED STUDY; DIALYSATE LEVEL; DIALYSIS; DRUG MECHANISM; FEMALE; HYPOTHERMIA; MALE; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SYMPATHETIC NERVE; TEMPERATURE MEASUREMENT; TRANSPORT KINETICS;

ANIMALS; CATS; CYANIDES; FEMALE; HYPOTHERMIA; MALE; NOREPINEPHRINE; OUABAIN; TYRAMINE;

EID: 0037216593     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Paton DM. The Mechanism of Neuronal and Extraneuronal Transport of Catecholamines. New York: Raven Press, 1975.
2. Bittner MA, Holz RW. A temperature-sensitive step in exocytosis. J Biol Chem 1992;267:16226-9.
3. Kitagawa H, Akiyama T, Yamazaki T. Effects of moderate hypothermia on in situ cardiac sympathetic nerve endings. Neurochem Int 2002;40:235-42.
4. Vizi ES. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: A simple method to separate the two types of release. Neurochem Int 1998;33:359-66.
5. Schömig A, Dart AM, Dietz R, Mayer E, Kübler W. Release of endogenous catecholamines in the ischemic myocardium of the rat. Circ Res 1984;55:689-701.
6. Schömig A, Fischer S, Kurz T, Richardt G, Schömig E. Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rate heart: Mechanism and metabolic requirements. Circ Res 1987;60:194-205.
7. Yamazaki T, Akiyama T, Kitagwa H, Takauchi Y, Kawada T, Sunagawa K. A new, concise dialysis approach to assessment of cardiac sympathetic nerve terminal abnormalities. Am J Physiol 1997;272:H1182-7.
8. Akiyama T, Yamazaki T, Ninomiya I. In vivo monitoring of myocardial interstitial norepinephrine by dialysis technique. Am J Physiol 1991;261:H1643-7.
9. Yamazaki T, Akiyama T, Shindo T. Routine high-performance liquid chromatographic determination of myocardial interstitial norepinephine. J Chromatogr B 1995;670:328-31.
10. Sweadner KJ. Ouabain-induced norepinephrine release from intact rat sympathetic neurons: Evidence for carrier-mediated release. J Neurosci 1985;9:2397-406.
11. Bönisch H, Trendelenburg U. Mechanism of action of indirectly acting sympathomimetic amines. In: Trendelenburg U, Weiner N, eds. Handbook of Experimental Pharmacology. Catecholamine 1, Berlin: Springer, 1988;90:246-77.
12. Yamazaki T, Akiyama T, Kawada T. Effect of ouabain on in situ cardiac sympathetic nerve endings. Neurochem Int 1999;35:439-45.
13. Takauchi Y, Yamazaki T, Akiyma T. Tyramine-induced endogenous noradrenaline efflux from in situ cardiac sympathetic nerve ending in cats. Acta Physiol Scand 2000;168:287-93.
14. Yahagi N, Yamazaki T, Akiyama T. Either desipramine or TMB-8 suppresses cyanide-induced norepinephrine efflux from in vivo cardiac sympathetic nerve of cats. Brain Res 2000;864:157-61.
15. 1) and desipramine binding by N-ethylmaleimide (NEM). Naunyn-Schmiedebergs Arch Pharmakol 1988;337:633-6.
16. 3H] noradrenaline in rat hippocampal slices. Neuroscience 2001;104:761-8.